Здоровье
WHO declares mpox a public health emergency for the second time in two years
The World Health Organisation on Wednesday declared mpox a public health emergency for the second time in two years after a viral outbreak in the
Imfinzi has received priority review by the FDA for the treatment of lung cancer
AstraZeneca on Thursday the US Food and Drug Administration (FDA) said its top-selling cancer drug Imfinzi has received priority review for patients with limited-stage small-cell
Astellas’ gastric cancer therapy gets the go-ahead from UK regulator
The UK health regulator said it approved Astellas Pharma’s therapy to treat a type of gastric cancer. The monoclonal antibody, which will be marketed under
Bavarian Nordic will donate doses of mpox vaccine after declaring a state of emergency in Africa
Danish biotechnology company Bavarian Nordic said on Tuesday it would hand over 40,000 doses of its mpox vaccine to Africa’s main public health authority after
U.S. to expand beef testing for bird flu at slaughterhouses
The U.S. Department of Agriculture said Tuesday it will expand testing of beef entering the food supply for bird flu as part of its response
Novartis loses initial bid to block generic of best-selling heart drug
Novartis failed to persuade a federal court to bar generics maker MSN Pharmaceuticals from marketing its own version of Entresto, Novartis’ favoured drug, according to
Biden has allocated $150 million to fight tumours as part of the Cancer Moonshot programme
President Joe Biden on Tuesday will announce $150 million in new federal funding to develop technology to help surgeons successfully remove cancerous tumours, the White
J&J received sufficient support from plaintiffs for $6.5bn talc settlement
Johnson & Johnson has crossed a key threshold of support for its proposed $6.5 billion settlement of tens of thousands of lawsuits alleging that its
Pfizer’s RSV vaccine shows benefit in immunosuppressed adults
Pfizer said its respiratory syncytial virus (RSV) vaccine, Abrysvo, generated a strong immune response in a late-stage study of four groups of adults aged 18
US approves Ascendis Pharma’s therapy for hormone disorders
Ascendis Pharma said the US Food and Drug Administration approved its therapy to treat adult patients with a hormone disorder. This sent the drugmaker’s shares